[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352124-105":59,"doc-detail-352124-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","exploration-of-novel-hydroxamic-acid-based-candidates-integrating-chalcone-scaffold-cap-as-multitarget-hdac-inhibitors-design-anti-prostatic-cancer-assessment-in-silico-docking-and-molecular-dynamic-simulation","Exploration of novel hydroxamic acid-based candidates integrating chalcone scaffold cap as multitarget HDAC inhibitors - design, anti-prostatic cancer assessment, in silico docking and molecular dynamic simulation","","Two novel series of hydroxamic acid hybrids were designed and synthesized as anticancer agents through histone deacetylase (HDAC) isozyme inhibition. Antiproliferative activity was assessed against DU-145 and PC-3 (prostate cancer), and MG-63 (osteosarcoma) cell lines. Compound 5d showed the strongest potency against DU-145 and PC-3 with IC50 values of 0.93 and 1.05 μM and inhibited HDAC2, 4, 6, and 8. Docking and a 100 ns molecular dynamics simulation supported interaction stability, with apoptotic cell death and cell-cycle arrest. Results suggest potential treatment of prostate cancer with bone metastasis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exploration-of-novel-hydroxamic-acid-based-candidates-integrating-chalcone-scaffold-cap-as-multitarget-hdac-inhibitors-design-anti-prostatic-cancer-assessment-in-silico-docking-and-molecular-dynamic-simulation/352124/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exploration-of-novel-hydroxamic-acid-based-candidates-integrating-chalcone-scaffold-cap-as-multitarget-hdac-inhibitors-design-anti-prostatic-cancer-assessment-in-silico-docking-and-molecular-dynamic-simulation/352124.png","ImageObject",300,407,{"name":92,"@type":93},"LangkahRina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of the study on hydroxamic acid hybrids?","Question",{"text":112,"@type":113},"The study aimed to design and synthesize hydroxamic acid hybrid candidates that act as histone deacetylase (HDAC) inhibitors with multitarget anticancer potential.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which compound showed the highest potency and against which cell lines?",{"text":117,"@type":113},"Compound 5d was the most potent against DU-145 and PC-3 prostate cancer cell lines, with IC50 values of 0.93 and 1.05 μM.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanistic and computational evidence supported the selected compound?",{"text":121,"@type":113},"Mechanistic results showed apoptotic cell death and cell-cycle arrest patterns, while docking and a 100 ns molecular dynamics simulation confirmed high affinity and interaction stability with HDACs.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352124,1790143753,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893776,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Journal of EnzymE InhIbItIon and mEdIcInal chEmIstry 2026, Vol. 41, no. 1, 2711875  \n[https://doi.org/10.1080/14756366.2026.2711875](https://doi.org/10.1080/14756366.2026.2711875)  \nReseaRch aRticle    \nExploration of novel hydroxamic acid-based candidates integrating chalcone scaffold cap as multitarget HDAC inhibitors: design, anti-prostatic cancer assessment, in silico docking and molecular dynamic simulation  \naya i. abd el-hameeda, ibrahim M. salemb, Rasha M. allamc, Mariem M. arafatd, hossameldin a. azize,f, Zuhier a. awang, tarek s. ibrahimh, Omar alshazlya, eman a. M. Beshri,j, stefan Bräsek and Mamdouh F. a. Mohameda,e,f   \nadepatment of Pharmaceutical chemistry, faculty of Pharmacy, sohag university, sohag, Egypt; bdepartment of Pharmaceutical chemistry, faculty of Pharmacy, sphinx university, new assuit city, assiut, Egypt; cPharmacology department, medical and clinical research Institute, national research centre, dokki, cairo, Egypt; dcell culture unit, life science division,  \nnawah-scientific Inc, cairo, Egypt; edepartment of Pharmaceutical chemistry, faculty of Pharmacy, new Valley university, new Valley, Egypt; fdepartment of Pharmaceutical chemistry, faculty of Pharmacy, new Valley national university, new Valley, Egypt; gdepartment of clinical biochemistry, faculty of medicine, King abdulaziz university, Jeddah, saudi arabia; hdepartment of organic chemistry, faculty of Pharmacy, King abdulaziz university, Jeddah, saudi arabia; idepartment of medicinal chemistry, faculty of Pharmacy, minia university, minia, Egypt; jmedicinal chemistry department, faculty of Pharmacy, minia national university, new minia, Egypt; kInstitute for biological and chemical system, Karlsruhe Institute of technology, Karlsruhe, Germany  \nABSTRACT  \ntwo novel series of hydroxamic acid hybrids were designed and synthesised as anticancer agents via histone deacetylase isozymes (hDacs) inhibitors. antiproliferative effects of novel compounds were evaluated against DU-145 and Pc-3 (prostate cancer) and MG-63 (osteosarcoma) cell lines. compound 5d emerged as the most potent against DU-145 and Pc-3 (prostate cancer) with ic50 values of 0.93 and 1.05 µM, exhibiting inhibiting hDac 2, 4, 6, and 8 with ic50 values of 0.86, 0.17, 1.17, and 0.15 µM [respectively. as](respectively. as) a result, it was selected for mechanistic investigations. apoptotic cell death modality was predominantly detected in the three cell lines, accompanied by cell cycle arrest in the s phase in prostate cancer cell lines, whereas it caused cell cycle arrest in MG-63 osteosarcoma cells in the G0/G1 phase. Docking studies confirmed its high affinity for hDacs, and an atomistic standard 100 ns dynamic simulation supported the stability of these interactions. in conclusion, all these findings suggested the potential use of this compound for treating prostate cancer with bone metastasis.  \nGRAPHICAL ABSTRACT  \nARTICLE HISTORY  \nReceived 11 april 2026 Revised 21 July 2026 accepted 25 July 2026  \nKEYWORDS  \nchalcone; hDac inhibitors; targeted anticancer; prostate cancer; osteosarcoma  \nCONTACT mamdouh f. a. mohamed  [mamdouhfawzy3@yahoo.com](mamdouhfawzy3@yahoo.com)  department of Pharmaceutical chemistry, faculty of Pharmacy, sohag university, 82524- sohag, Egypt; stefan bräse  [braese@kit.edu](braese@kit.edu)  Institute for biological and chemical system, Karlsruhe Institute of technology, 76131 Karlsruhe, Germany.  \n supplemental data for this article can be accessed online at [https://doi.org/10.1080/14756366.2026.2711875](https://doi.org/10.1080/14756366.2026.2711875) .  \n© 2026 the author(s) . Published by Informa uK limited, trading as taylor & francis Group.  \nthis is an open access article distributed under the terms of the creative commons attribution license ([http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/)), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is proper","cbCaigDoEpS1owny","https://ap.wps.com/l/cbCaigDoEpS1owny","pdf",4013737,33,"English","# Abstract\n# Graphical Abstract\n# Article History\n# Keywords\n# Introduction","[{\"question\":\"What was the main goal of the study on hydroxamic acid hybrids?\",\"answer\":\"The study aimed to design and synthesize hydroxamic acid hybrid candidates that act as histone deacetylase (HDAC) inhibitors with multitarget anticancer potential.\"},{\"question\":\"Which compound showed the highest potency and against which cell lines?\",\"answer\":\"Compound 5d was the most potent against DU-145 and PC-3 prostate cancer cell lines, with IC50 values of 0.93 and 1.05 μM.\"},{\"question\":\"What mechanistic and computational evidence supported the selected compound?\",\"answer\":\"Mechanistic results showed apoptotic cell death and cell-cycle arrest patterns, while docking and a 100 ns molecular dynamics simulation confirmed high affinity and interaction stability with HDACs.\"}]","Exploration of novel hydroxamic acid-based candidates integrating chalcone scaffold cap as multitarget HDAC inhibitors - design, anti-prostatic cancer assessment, in silico docking and molecular dynamic simulation | PDF",1790097808,83,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8abead4233b0909415665df08cce5f42.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/086606843c9af3801924eaa101438946.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d15267cd4dad654fcedcf8ba970a749a.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/566998e143015228bd1cab49406c590b.webp",980,1306]